Addictions	Bipolar	Depression	Eating Disorders	Genetic	Personality Disoder	Learning Disabilities
Psychological Distress	Psychosis	Schizophrenia	Unexplained Symptoms	Aspergers Syndrome	Autism	Other

fNEMO Neuropsychological function as a result of chronic exposure to methadone and other opiates (NEMO): neural responses to rewards - a study using functional magnetic resonance imaging (fMRI)	Chief Investigator Dr Alex Baldacchino

A clinical, neuropsychological and magnetic resonance imaging study comparing autism spectrum disorders and schizophrenia spectrum disorders A clinical, neuropsychological and magnetic resonance imaging study comparing autism spectrum disorders and schizophrenia spectrum disorders	Chief Investigator Dr Andrew Stanfield

Efficacy of a group based social skills intervention in adults with Asperger syndrome Efficacy of a group based social skills intervention in adults with Asperger syndrome	Chief Investigator Dr Andrew Stanfield

CEQUEL Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression.	Chief Investigator Professor John Geddes
BFS Bipolar Family Study	Chief Investigator Dr Andrew McIntosh
Molecular Study Molecular Genetic Investigation of Bipolar Disorder and Related Mood Disorder	Chief Investigator Professor Nick Craddock
Emotional processing in Bipolar Disorder Emotional processing in Bipolar Disorder	Chief Investigator Dr Jess Sussmann
A pilot randomised controlled trial of Cognitive Behaviour Therapy for early bipolar disorder. A pilot randomised controlled trial of Cognitive Behaviour Therapy for early bipolar disorder.	Chief Investigator Dr Jamie Kirk

ProCEED Evaluation of a system of structured, pro-active care for chronic depression in primary care	Chief Investigator Dr Marta Buszewicz
SMaRT Oncology-2 Trial Symptom Management Research Trials - SMaRT Oncology-2 Trial	Chief Investigator Professor Michael Sharpe
SMaRT Oncology-3 Pilot Symptom Management Research Trials - SMaRT Oncology-3 Pilot	Chief Investigator Professor Michael Sharpe
SMaRT Oncology-3 Trial Symptom Management Research Trials - SMaRT Oncology-3 Trial	Chief Investigator Professor Michael Sharpe
GCIT Evaluation of cognitive interpersonal group Evaluation of cognitive interpersonal group therapy for psychosis	Chief Investigator Dr Christine Braehler
Diffusion Tensor and Functional Imaging of Chronic Treatment Refractory Depression and Neurosurgical Treatments DTFI	Chief Investigator Prof Douglas Steele
COBALT Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: a randomised controlled trial	Chief Investigator Dr Nicola Wiles
DBS A clinical evaluation for the management of patients with Major Depressive Disorder, single or recurrent episode, with deep brain stimulation.	Chief Investigator Professor Keith Matthews
SPECT The effects of TNF blockade (using etanercept) on substrates of mood and cognition in patients with inflammatory arthritis.	Chief Investigator Dr Jonathan Cavanagh
ISA Inflammatory Bowel Disease, Steroids and Affective Disorder	Chief Investigator Dr Benjamin Baig
CBASP Intensive psychotherapy for chronic, treatment-resistant depression: a pilot investigation of clinical effectiveness and mediators of learning in the Cognitive Behavioural Analysis System of Psychotherapy (CBASP)	Chief Investigator John Swan
KANECT The use of Ketamine as an anaesthetic during electroconvulsive therapy (ECT) for depression: does it improve treatment outcome?	Chief Investigator Professor Ian Reid
ASPEN Anti-Stigma Partnership European Network	Chief Investigator Professor Graham Thornicroft

iMANTRA-R Internet-based relapse prevention for in-patients with Anorexia Nervosa	Chief Investigator Professor Ulrike Schmidt

Scottish Family Genetic Colloboration Scottish Family Genetic Collaboration	Chief Investigator Dr Andrew McIntosh
GS SFHS Generation Scotland: Scottish Family Health Study	Chief Investigator Professor Andrew Morris

DownsLit Genetically determined brain abnormalities in Down’s syndrome – towards a treatment	Chief Investigator Professor Declan Murphy
A multi-centre phase 3 Cluster randomized controlled trial of a manualized anger management intervention for people with mild to moderate learning disabilities A multi-centre phase 3 Cluster randomized controlled trial of a manualized anger management intervention for people with mild to moderate learning disabilities	Chief Investigator Professor Paul Willner
NOVARTIS A randomised, double blind, placebo-controlled, parallel group study to evaluate AFQ056 in adult patients with Fragile X Syndrome	Chief Investigator Dr Andrew Stanfield

A Neuropsychological Study of Emotion Regulation and Impulsivity A Neuropsychological Study of Emotion Regulation and Impulsivity	Chief Investigator Dr Jeremy Hall
ENGAGE Meeting mental health needs of complex co-morbid patients following a suicide attempt. A pilot study.	Chief Investigator Prof Kate Davidson

PODS Persistence of distress in cancer outpatients: a symptom follow-up study	Chief Investigator Prof Michael Sharpe

EDIE 2 Early Detection and Intervention Evaluation for individuals at high risk of psychosis (2)	Chief Investigator Dr Anthony Morrison
PACT Acceptance and Commitment Therapy for Psychosis	Chief Investigator Dr Ross White

Scottish Family Mental Health Study Brain imaging studies of pre-frontal glutamate concentration, perfusion and activity.	Chief Investigator Prof Stephen Lawrie
LD Rescan Further studies of mental health in young people with additional learning needs.	Chief Investigator Prof David Owens
Trust in Schizophrenia investigated with an Economics Game Paradigm Trust in Schizophrenia investigated with an Economics Game Paradigm	Chief Investigator Dr James Currie
A single sequence, open-label, methodology study to assess cognitive change in patients with schizophrenia after supervised training with the Brain Fitness Program A single sequence, open-label, methodology study to assess cognitive change in patients with schizophrenia after supervised training with the Brain Fitness Program	Chief Investigator
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms	Chief Investigator Professor Bill Deakin
Roche negative Study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics followed by a 28 week, doubleblind treatment period	Chief Investigator Professor John Geddes
Roche sub-optimal Study to evaluate the efficacy and safety of RO4917838 in patients with sub-optimally controlled symptoms of schizophrenia treated with antipsychotics followed by a 40-week double-blind, parallel group, placebo-controlled treatment period.	Chief Investigator Professor John Geddes

MSS Multiple Symptom Study	Chief Investigator Dr Chris Burton